Native mycotoxin-inhibiting genes in common beans for crop protection

Overview

This research identifies native genes in common beans (Phaseolus vulgaris) that inhibit the production of mycotoxins by the fungal pathogen Fusarium verticillioides. Laboratory experiments demonstrated that while the fungus grows normally on common beans, it fails to produce mycotoxins on five local bean varieties—unlike on maize or rice, where high toxin concentrations accumulate. These findings suggest that resistance-related genes activate in common beans before or upon fungal infection, offering a promising novel genetic strategy for managing mycotoxins in other staple crops and contributing to global food security.

Technical specifications

Key features:

• In vitro validation using five local common bean varieties inoculated with standardized F. verticillioides spore concentrations under optimal conditions for mycotoxin production
• Statistical confirmation that mycotoxin levels were undetectable on common beans despite comparable fungal growth across substrates
• Planned transcriptomic analysis of bean grains to identify expressed genes and biosynthetic pathways triggered by fungal infection
• MicroRNA profiling to evaluate potential gene-silencing factors involved in the resistance response
• Fungal transcriptome analysis to determine whether mycotoxin biosynthesis genes are downregulated during infection of bean tissue

Applications:

• Genetic engineering or marker-assisted breeding to transfer mycotoxin-resistance traits into maize, rice, and other susceptible grains
• Identification of candidate genes and regulatory elements for crop improvement programs
• Foundation for developing biocontrol or natural-resistance strategies in agricultural food safety

Technology readiness level

The research is at an early discovery stage (TRL 2–3). In vitro laboratory validation has confirmed the phenomenon across multiple bean varieties, and transcriptomic and microRNA analyses are planned as next steps to identify the specific genes and pathways responsible. The team is actively seeking partnerships that provide equipment and materials for transcriptomic analysis as well as funding for key personnel to advance the research toward gene identification and potential translational applications.